Presence of sildenafil and tadalafil may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels.
Dietary supplements containing ephedrine alkaloids pose a risk of serious adverse events, including heart attack, stroke, and death.
A slow or improper driveline changeover places certain patients at risk of serious injury or death.
Use or consumption of products containing SARMs and anabolic steroid-like substances may cause acute liver injury, which is known to be a possible harmful effect of using steroid containing products.
Unexpected stop in ventilation therapy may cause serious adverse health consequences, including death.
Health care professionals should continue to limit GBCA use to circumstances in which additional information provided by the contrast agent is necessary, and assess the necessity of repetitive MRIs with GBCAs.
L'Agenzia Europea dei Medicinali (EMA) ha
raccomandato modifiche alle informazioni del prodotto per gli antibiotici a
base di vancomicina al fine di garantire un uso appropriato nel trattamento
delle infezioni gravi causate da batteri Gram-positivi.
Falsely lower test results may lead to improper patient management and treatment for lead exposure or poisoning.
Potential risks associated with balloon inflation and deflation difficulties include air embolism, additional intervention, thrombosis, and myocardial infarction.
New warnings, including a Boxed Warning, to be added to the canagliflozin drug labels.
80.211.154.110
